Articles

1. Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia

   • Xiaochen Wu
   • Zhanmeng Cao
   • Benshang Li

   Research Open access 25 April 2024 Article: 87

   

2. A novel diagnostic model based on lncRNA PTPRE expression, neutrophil count and red blood cell distribution width for diagnosis of seronegative rheumatoid arthritis

   • Jinfang Xia
   • Huali Gao
   • Jinpiao Lin

   Research Open access 25 April 2024 Article: 86

   

3. miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression

   • Amirhossein Mohajeri Khorasani
   • Samane Mohammadi
   • Pegah Mousavi

   Review Open access 25 April 2024 Article: 85

   

4. Fibroblast expression of neurotransmitter receptor HTR2A associates with inflammation in rheumatoid arthritis joint

   • Chunyan Xiang
   • Soon-Min Hong
   • Runci Wang

   Research Open access 25 April 2024 Article: 84

   

5. Extrachromosomal circular DNA (eccDNA): from carcinogenesis to drug resistance

   • Zhaoxing Li
   • Daohai Qian

   Review Open access 25 April 2024 Article: 83

   

6. Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL)

   • Katrin Seidenstuecker
   • Sonia Fertsch
   • Elisabeth A. Kappos

   Research Open access 23 April 2024 Article: 82

   

7. Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study

   • Netanella Danielli Miller
   • Nitzan Goren Gepstein
   • Amir Wiser

   Research Open access 23 April 2024 Article: 81

   

8. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

   • Job P. van Kooten
   • Michelle V. Dietz
   • Jan H. von der Thüsen

   Research Open access 20 April 2024 Article: 80

   

9. Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study

   • Jing Zhao
   • Xiaoning Wang
   • Wenjuan Zhu

   Research Open access 18 April 2024 Article: 79

   

10. Comparison of trace elements in peripheral blood and bone marrow of newly diagnosed multiple myeloma patients

    • Ayse Nilgun Kul
    • Bahar Ozturk Kurt

    Research Open access 17 April 2024 Article: 78

11. Clinical impact of transient lymphopenia

    • Luigi Petramala
    • Cinzia Milito
    • Claudio Letizia

    Research Open access 17 April 2024 Article: 77

    

12. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study

    • Jiayu Huang
    • Jiazhi Wang
    • Yongfu Zhao

    Research Open access 12 April 2024 Article: 76

    

13. The prevalence of chronic obstructive pulmonary disease in patients with spondyloarthritis compared to the general population in the southernmost region of Sweden: a case–control study

    • Petros Zamout
    • Sofia Exarchou
    • Carl Turesson

    Research Open access 10 April 2024 Article: 75

14. A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers

    • Anna Barbato
    • Fabiola Piscopo
    • Pietro Carotenuto

    Research Open access 10 April 2024 Article: 74

    

15. Supporting the decision to perform molecular profiling for cancer patients based on routinely collected data through the use of machine learning

    • Julia Kasprzak
    • C. Benedikt Westphalen
    • Daniel Nasseh

    Research Open access 10 April 2024 Article: 73

    

16. Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort

    • Fulvia Ceccarelli
    • Francesco Natalucci
    • Fabrizio Conti

    Research Open access 10 April 2024 Article: 72

    

17. Retraction Note: Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives

    • Wen-chao Zhou
    • Qun-feng Zhang
    • Juan Zou

    Retraction Note 06 April 2024 Article: 71

18. Low platelet count at diagnosis of anti-neutrophil cytoplasmic antibody-associated vasculitis is correlated with the severity of disease and renal prognosis

    • Yanli Jin
    • Fangyuan Wang
    • Xiaozhao Li

    Research Open access 05 April 2024 Article: 70

    

19. Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies

    • Valentina Giudice
    • Monica Ianniello
    • Carmine Selleri

    Research Open access 05 April 2024 Article: 69

    

20. Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences

    • Takashi Hirama
    • Yuki Shundo
    • Yoshinori Okada

    Research Open access 05 April 2024 Article: 68

21. Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

    • Marie Boudna
    • Tana Machackova
    • Ondrej Slaby

    Research Open access 03 April 2024 Article: 67

    

22. Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

    • Yizi Gong
    • Chanjuan Shen
    • Yong Zhong

    Research Open access 02 April 2024 Article: 66

    

23. The casual relationship between autoimmune diseases and multiple myeloma: a Mendelian randomization study

    • Peipei Jin
    • Xiaoqing Jin
    • Zhuo Zhan

    Research Open access 02 April 2024 Article: 65

    

24. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma

    • Mengdi Wan
    • Wei Zhang
    • Tongyu Lin

    Research Open access 30 March 2024 Article: 64

    

25. Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders

    • Julia Wagenpfeil
    • Katharina Hoß
    • Claus Christian Pieper

    Research Open access 30 March 2024 Article: 63

    

26. Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort

    • Stefano Gentileschi
    • Carla Gaggiano
    • Serena Guiducci

    Research Open access 30 March 2024 Article: 62

    

27. External validation of a four-tiered grading system for chromophobe renal cell carcinoma

    • Shuai Liu
    • Mingyu Hou
    • Guiming Zhang

    Research Open access 30 March 2024 Article: 61

    

28. Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients

    • Ting Mei
    • Ting Wang
    • Qinghua Zhou

    Review Open access 30 March 2024 Article: 60

    

29. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis

    • Mohammad Reza Eskandarion
    • Sharareh Eskandarieh
    • Reza Shirkoohi

    Review Open access 30 March 2024 Article: 59

    

30. Role of albumin infusion in cirrhosis-associated complications

    • Mohamed A. Heybe
    • Kosha J. Mehta

    Review Open access 29 March 2024 Article: 58

    

31. Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia

    • Qianqian Hao
    • Yu Liu
    • Ling Sun

    Research Open access 28 March 2024 Article: 57

    

32. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia

    • Li-Xin Wu
    • Ming-Yue Zhao
    • Guo-Rui Ruan

    Research Open access 28 March 2024 Article: 56

    

33. Circulating Bone morphogenetic protein 9 (BMP9) as a new biomarker for noninvasive stratification of nonalcoholic fatty liver disease and metabolic syndrome

    • Yuchen Yang
    • Meihong Gu
    • Lan Zhong

    Research Open access 16 March 2024 Article: 55

    

34. Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment

    • Xin Zhang
    • Hua Wang
    • Xin Wang

    Review Open access 16 March 2024 Article: 54

    

35. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.

    • Celine Man Ying Li
    • Matthew T. Briggs
    • Kevin Fenix

    Research Open access 16 March 2024 Article: 53

    

36. Non-tumor-related prognostic factors for immunotherapy–chemotherapy or immunotherapy alone as first-line in advanced non-small cell lung cancer (NSCLC)

    • Ziwei Guo
    • Xing Wei
    • Jun Liang

    Research Open access 15 March 2024 Article: 52

    

37. Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma

    • Filippo Bagnoli
    • Giuditta Pini
    • Emilio Berti

    Case Report Open access 05 March 2024 Article: 51

    

38. RUNX transcription factors: biological functions and implications in cancer

    • Xinyi Chen
    • Lu Wang
    • Xianglin Yuan

    Review Open access 02 March 2024 Article: 50

    

39. Research progress on the multi-omics and survival status of circulating tumor cells

    • Qingming Xie
    • Shilei Liu
    • Pengfei Zhang

    Review Open access 01 March 2024 Article: 49

    

40. Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcome

    • Hongyun Chen
    • Jinrong Zhao
    • Wei Zhang

    Research Open access 01 March 2024 Article: 48

    

41. Sex-specific differences in ICOS⁺ T helper cell differentiation in systemic lupus erythematosus patients with low disease activity

    • Lisa Wu
    • Florian Kälble
    • Andrea Steinborn

    Research Open access 01 March 2024 Article: 47

    

42. Therapeutic potential of mesenchymal stem cell-derived exosomes for regenerative medicine applications

    • Szymon Roszkowski

    Review Open access 01 March 2024 Article: 46

    

43. Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation and disease progression in cirrhosis

    • Lichen Xu
    • Chunhong Huang
    • Zhi Chen

    Research Open access 28 February 2024 Article: 45

    

44. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma

    • Xichun Kang
    • Xiling Liu
    • Huimin Yan

    Research Open access 28 February 2024 Article: 44

    

45. Clinical and pathological findings of IgA nephropathy following SARS-CoV-2 infection

    • Hongfen Li
    • Zhao Li
    • Tiekun Yan

    Research Open access 24 February 2024 Article: 43

    

46. Causality between COVID-19 and multiple myeloma: a two-sample Mendelian randomization study and Bayesian co-localization

    • Shuaiyuan Wang
    • Na Zhao
    • Kuisheng Chen

    Research Open access 24 February 2024 Article: 42

    

47. Immunomodulatory effects of iTr35 cell subpopulation and its research progress

    • Chenxi Yang
    • Lingli Dong
    • Jixin Zhong

    Review Open access 22 February 2024 Article: 41

    

48. Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration

    • Amélia Lessard-Roy
    • Roxanne Marchand
    • Danielle Laurin

    Research Open access 22 February 2024 Article: 40

    

49. Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis

    • Xiaxin Zhu
    • Chi Zhang
    • Shuo Zhang

    Review Open access 22 February 2024 Article: 39

    

50. Role of zinc in health and disease

    • Lucy I. Stiles
    • Kevin Ferrao
    • Kosha J. Mehta

    Review Open access 17 February 2024 Article: 38